Pharmacons ApS: Financial statements 2023
CVR: 36892870
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
Pharmacons ApS (CVR 36892870) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -61,051 and a net result of DKK -61,739 compared with DKK -9,122 the year before. Equity in the 2023 report amounted to DKK 81,512. The solvency ratio was 81.1%.
- Gross Profit
- DKK -61,051
- Profit/Loss
- DKK -61,739
- Equity
- DKK 81,512
- Total Assets
- DKK 100,456
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -61 t. | -62 t. | 82 t. | - |
| 2022 | - | -11 t. | -9 t. | 143 t. | - |
| 2021 | - | -40 t. | -32 t. | 152 t. | - |
| 2020 | - | 22 t. | 20 t. | 184 t. | - |
| 2019 | - | 83 t. | 44 t. | 164 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Pharmacons ApS
Pharmacons ApS was a Danish company of the type Anpartsselskab based in Helsingør, founded in 2015. The company has been dissolved on 26 May 2025. The company was registered under the industry Anden teknisk rådgivning. The company has 0 employees (2018). In 2024, the company reported a gross profit of DKK -17,821 and a net result of DKK -18,480 compared with DKK -61,739 the year before. Equity in the 2024 report amounted to DKK 63,032.